Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial
拉达瑞辛（一种白细胞介素-8受体CXCR1和CXCR2抑制剂）治疗新发1型糖尿病：一项多中心、随机、双盲、安慰剂对照试验
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14770
Piemonti, Lorenzo; Keymeulen, Bart; Gillard, Pieter; Linn, Thomas; Bosi, Emanuele; Rose, Ludger; Pozzilli, Paolo; Giorgino, Francesco; Cossu, Efisio; Daffonchio, Luisa; Goisis, Giovanni; Ruffini, Pier Adelchi; Maurizi, Anna Rita; Mantelli, Flavio; Allegretti, Marcello
CR2
CR1
信号转导
代谢
CXCR2
糖尿病
细胞生物学
